Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Glioblastoma 1 Epilepsy 1

Interventions

Cytarabine 81 Azacitidine 66 venetoclax 55 fludarabine 34 fludarabine phosphate 31 Decitabine 28 Cyclophosphamide 28 Idarubicin 24 Peripheral Blood Stem Cell Transplantation 22 Filgrastim 20 Granulocyte Colony-Stimulating Factor 18 Busulfan 18 Mitoxantrone 16 Etoposide 16 Whole-Body Irradiation 15 Mycophenolic Acid 14 Cyclosporine 14 Tacrolimus 13 Melphalan 13 Daunorubicin 13 Clofarabine 13 Methotrexate 12 gilteritinib 11 aldesleukin 11 plerixafor 10 Injections 10 decitabine and cedazuridine drug combination 9 Gemtuzumab 9 Cladribine 9 quizartinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Leukemia, Myeloid, Acute × Sulfasalazine × Clear all

NCT05580861 2024-05-29

SALMA

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡